Phase II study of cetuximab with irinotecan for KRAS wild-type colorectal cancer in Japanese patients.
Terazawa T, Nishitani H, Kato K, Hashimoto H, Akiyoshi K, Ito Y, Nakamoto A, Iwasa S, Nakajima TE, Hamaguchi T, Yamada Y, Shimada Y.
Terazawa T, et al. Among authors: nishitani h.
Asia Pac J Clin Oncol. 2017 Apr;13(2):e132-e137. doi: 10.1111/ajco.12405. Epub 2015 Aug 6.
Asia Pac J Clin Oncol. 2017.
PMID: 26245851
Clinical Trial.